APT Medical Inc. Class A

As of June 30, 2026, APT Medical Inc. Class A carries a market capitalization of 25.70B, placing it among publicly traded companies globally. Its enterprise value stands at 24.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

APT Medical Inc. Class A's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, APT Medical Inc. Class A has 141.53M shares outstanding.

As of June 30, 2026, APT Medical Inc. Class A trades at a trailing price-to-earnings ratio of 26.06. The price-to-sales ratio is 8.80, and the price-to-book ratio stands at 8.32.

As of June 30, 2026, APT Medical Inc. Class A trades at an EV/EBITDA multiple of 22.00 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 8.41 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 22.00 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 24.32B versus a market cap of 25.70B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, APT Medical Inc. Class A maintains a current ratio of 4.67, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.44, indicating conservative leverage, while an interest coverage ratio of 2,819.46 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, APT Medical Inc. Class A posted a return on equity (ROE) of 33.75, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 32.33 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 28.88, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 33.79, useful for judging operating efficiency across full business cycles. The company generates approximately 971,490.40 in revenue per employee across its workforce of 2,977.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.72 indicates how many times APT Medical Inc. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, APT Medical Inc. Class A recorded 139.72M in income tax expense. That works out to an effective tax rate of 12.71, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.10B, leaving 976.66M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, APT Medical Inc. Class A's stock has declined approximately 18.29% over the past 52 weeks. The 50-day moving average sits at 242.94, while the 200-day moving average is 231.95.

Over the twelve months ended June 30, 2026, APT Medical Inc. Class A generated 2.89B in revenue and converted that into 976.66M in net income, yielding earnings per share of 6.82. EBITDA reached 1.11B, while operating income came in at 1.11B.

As of June 30, 2026, APT Medical Inc. Class A holds 1.42B in cash and equivalents against 13.74M in total debt, resulting in a net debt position of -1.35B. Total book value stands at 3.09B, with working capital of 1.61B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, APT Medical Inc. Class A posted a gross margin of 72.95, reflecting its pricing power and cost economics. The operating margin of 38.54 and net profit margin of 33.77 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, APT Medical Inc. Class A paid dividends of 2.21 per share. The dividend payout ratio of 32.84 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 3.23, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to APT Medical Inc. Class A shareholders.

APT Medical Inc. Class A's most recent stock split took place on June 19, 2025 with a 20:29 split ratio.

As of June 30, 2026, APT Medical Inc. Class A has an Altman Z-Score of 34.75, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.